Monday, November 23, 2009, 8:41pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

DexCom, Inc. (DXCM)

 At 16:00 EST: 7.39 USD  Up 0.12 (1.65%)  
MORE ON DXCM
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
DexCom, Inc. (NGM:DXCM) Delayed quote dataEdit
After Hours: 7.39 Down 0.00 (0.02%) as of 4:13pm EST on 11/23/09
Last Trade: 7.39 USD
Trade Time: 4:00PM EST
Change: Up 0.12 (1.65%)
Prev Close: 7.27
Open: 7.51
Bid: 6.50 x 100
Ask: N/A
1y Target Est: 8.70
Day's Range: 7.34 - 7.54
52wk Range: 1.42 - 8.96
Volume: 128,727
Avg Vol (3m): 247,959
Market Cap: 340.17M
P/E (ttm): N/A
EPS (ttm): -1.31
Div & Yield: N/A (N/A%)
DexCom, Inc. (DXCM)
1d  5d  3m  6m  1y  2y  5y 
 Add DXCM to Portfolio   Download Data

HEADLINES
• DexCom Appoints Nicholas Augustinos as Board Member
Business Wire (Mon 4:13pm)
• DEXCOM INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
EDGAR Online (Mon 4:11pm)
• DexCom To Present at Lazard Capital Markets 6th Annual Healthcare Conference
Business Wire (Mon, Nov 16)
• DexCom Loss Narrows on Higher Revenue
Zacks.com (Fri, Nov 13)
• DEXCOM INC Financials
EDGAR Online Financials (Tue, Nov 10)
• New Star Analyst Rankings for DexCom, Inc.
StarMine (Thu, Nov 5)
• DEXCOM INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Wed, Nov 4)
• DexCom Inc. Reports Third Quarter 2009 Financial Results
Business Wire (Wed, Nov 4)
• Q3 2009 DexCom, Inc. Earnings Release - After Market Close
CCBN (Wed, Nov 4)
• Edwards Lifesciences and DexCom Announce Receipt of CE Mark for Glucose Monitoring System
Marketwire (Mon, Nov 2)
• DexCom Schedules Third Quarter 2009 Earnings Release and Conference Call for November 4, 2009
Business Wire (Tue, Oct 27)
More Headlines for DXCM...
ANALYST
EPS Est (next year) (Dec-09) : -1.24
EPS Est (in 2 years) (Dec-10) : -0.94
Avg Rec (current)*: 1.9
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices